Dominari HoldingsDOMH
DOMH
About: Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
Employees: 28
0
Funds holding %
of 6,735 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
15% more funds holding
Funds holding: 13 [Q2] → 15 (+2) [Q3]
0.45% less ownership
Funds ownership: 7.76% [Q2] → 7.3% (-0.45%) [Q3]
2% less capital invested
Capital invested by funds: $862K [Q2] → $849K (-$13.1K) [Q3]
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Research analyst outlook
We haven’t received any recent analyst ratings for DOMH.
Financial journalist opinion
Charts implemented using Lightweight Charts™